Statistics for AbbVie (id:8478 ABBV)
Valuation metrics
Market cap
310.93B
Enterprise value
367.18B
Trailing P/E (ttm)
61.52
Forward P/E
14.51
PEG ratio
14.51
Price/Sales (ttm)
5.60
Price/Book (mrq)
51.55
Enterprise Value/Revenue
6.61
Enterprise Value/EBITDA
14.33
Overview
Shares outstanding
1.77B
Float
1.76B
Shares short
19.32M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
5.60M
Average volume (90 days)
Price summary
52-Week low
153.58
52-Week high
207.32
52-Week change
11.94%
Beta
3.00
50-Day moving average
183.14
200-Day moving average
178.86
Dividends and splits
Forward annual dividend rate
6.20
Forward annual dividend yield
5.00
Trailing annual dividend rate
6.20%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
4.13
Payout ratio
2.14
Dividend date
February 14, 2025
Ex-dividend date
January 15, 2025
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
9.22%
Operating margin
28.93%
Operational effectiveness
Return on assets
7.72%
Return on equity
56.41%
Income statement
Revenue (ttm)
31.40
Revenue per share (ttm)
31.40
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
33.90B
EBITDA
19.46B
Net income to common (ttm)
5.08B
Diluted EPS (ttm)
2.86
Quarterly earnings growth (yoy)
-12.20%
Balance sheet
Total cash (mrq)
7.29B
Total cash per share (mrq)
4.12
Total debt (mrq)
71.32B
Total Debt/Equity (mrq)
1.17K
Current ratio (mrq)
64.50%
Book value per share (mrq)
3.41
Cash flow
Cash flow statement
16.51B
Levered free cash flow (LFCF)
17.74B